Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: If you don’t love the skin you’re in

Have you ever wanted to shed your skin? I don’t mean in the metaphorical sense like becoming a different person, free of all the old baggage we accumulate in life. And I’m not talking about CCRM’s new logo and colours either, but thanks for noticing. (Shameless.) I...

Update from the Clinic: March

Welcome to your Update from the Clinic for the month of March. Undoubtedly the big news in March came from Vericel, which saw its stock double after reporting positive topline results from its Phase 2b study in heart failure. There were also some first dosings and...

Cell Therapy Deal Review: March

Welcome to your Cell Therapy Deal Review for the month of March. Cellectis continues to differentiate through a collaboration with MabQuest. PCT formed a partnership with Japanese conglomerate Hitachi. Kite partnered with Roche’s Genentech on a program for lymphoma....

A double duty scaffold for cell delivery to the brain

Neurodegenerative diseases of the brain, such as Parkinson’s and Alzheimer’s, are a leading cause of disability in Canada, but despite the significant burden on patients, caregivers and the health-care system, we still lack a cure. An active area of research for these...